Literature DB >> 12066104

Factors affecting the likelihood of successful induction after intravaginal misoprostol application for cervical ripening and labor induction.

Deborah A Wing1, Susan Tran, Richard H Paul.   

Abstract

OBJECTIVE: Our purpose was to determine whether maternal age, height and weight, parity, duration of pregnancy, cervical dilatation or Bishop score, and birth weight could be used to predict the likelihood of successful induction in women given intravaginal misoprostol. STUDY
DESIGN: A computerized database was compiled of 1373 pregnancies in which intravaginal misoprostol was given for cervical ripening and labor induction. Most of these women were placed on investigational protocols in which the dose of misoprostol administered was 25 to 50 microg and the dosing intervals ranged from 3 to 6 hours. No more than 24 hours of administration was permitted. Induction was undertaken in women with unfavorable cervical examinations (Bishop scores of 4 or less) and without spontaneous labor or ruptured membranes. Univariate and stepwise multiple regression analyses were performed to identify those factors associated with successful induction, defined as vaginal delivery within 24 hours of induction.
RESULTS: Six hundred fifty-seven (48%) had successful induction. Parity (odds ratio [OR] 2.5, 95% CI 2.0-2.9, P <.0001), initial cervical dilatation (OR 1.9, 95% CI 1.6-2.3, P <.0001), Bishop score (OR 1.6, 95% CI 1.3, 1.8, P <.0001), and gestational age at entry (OR 1.3, 95% CI 1.1-1.5, P =.002) were significant at the.05 level for predicting successful induction. A multivariate stepwise logistic regression was then performed to evaluate each of these as independent predictors. Parity (OR 2.4, 95% CI 2.0-3.0, P <.0001), initial cervical dilatation (OR 1.7, 95% CI 1.4-2.1, P <.0001), and estimated gestational age (OR 1.3, 95% CI 1.1-1.6, P =.003) are significant independent predictors for successful induction, but initial Bishop score is not significant (P =.19) after adjustment for other significant predicting factors.
CONCLUSIONS: The clinical characteristics of parity, initial cervical dilatation, and gestational age at entry are predictors of the likelihood of success of cervical ripening and labor induction with intravaginal misoprostol administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12066104     DOI: 10.1067/mob.2002.123740

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Misoprostol for pre-term labor induction in the second trimester: Role of medical history and clinical parameters for prediction of time to delivery.

Authors:  Alexander di Liberto; Jan Endrikat; Sandra Frohn; Erich Solomayer; Kubilay Ertan
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

Review 2.  Timing of delivery in women with diabetes in pregnancy.

Authors:  Howard Berger; Nir Melamed
Journal:  Obstet Med       Date:  2014-01-15

3.  Comparison of two dosing regimens of vaginal misoprostol for labour induction: a randomised controlled trial.

Authors:  Shivarudraiah Girija; Attibele Palaksha Manjunath
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-12-01

4.  A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study.

Authors:  Kjersti Engen Marsdal; Ingvil Krarup Sørbye; Lise C Gaudernack; Mirjam Lukasse
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-05       Impact factor: 3.007

5.  Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan.

Authors:  Rawan A Obeidat; Mahmoud Almaaitah; Abeer Ben-Sadon; Dina Istaiti; Hasan Rawashdeh; Shereen Hamadneh; Hanan Hammouri; Adel Bataineh
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-07       Impact factor: 3.007

6.  Clinical parameters for prediction of successful labor induction after application of intravaginal dinoprostone in nulliparous Chinese women.

Authors:  Lei Hou; Yu Zhu; Xiaomin Ma; Jianing Li; Weiyuan Zhang
Journal:  Med Sci Monit       Date:  2012-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.